Skip to content

Clinical trials

Terminated Inflammation trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Status: Terminated Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20111
20131
20171
20182
20191
20201
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
University of Alberta2
Atara Biotherapeutics1
Centre hospitalier de l'Université de Montréal (CHUM)1
Laurent Pharmaceuticals Inc.1
Luciano A. Sposato1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Montreal Heart Institute1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Northern Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation15
Crohn Disease3
Acute Coronary Syndrome1
Asthma1
Atherosclerosis1
Autoimmune Diseases1
Burns1
Coronary Artery Disease1
Cystitis, Interstitial1
Demyelinating Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.